<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Vulto A</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To compare cortisol pharmacokinetics and pharmacodynamics mapped through several glucocorticoid sensitive pathways in patients on hydrocortisone substitution with or without an adrenal crisis.&lt;h4>Design&lt;/h4>A &lt;i>post-hoc&lt;/i> analysis of a previously conducted randomized controlled trial in patients with secondary adrenal insufficiency examining the effects of 2 weight-adjusted hydrocortisone doses.&lt;h4>Methods&lt;/h4>Comparisons were primarily made on a hydrocortisone dose of 0.2-0.3 mg/kg/day for plasma cortisol and cortisone, 24-hour urinary steroid profile, the glucocorticoid sensitive tryptophan-kynurenine pathway, the renin-angiotensin-aldosterone system and aspects of quality of life. Variables of interest were also analyzed on the hydrocortisone dose of 0.4-0.6 mg/kg/d</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>849188</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9065259</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Susceptibility to Adrenal Crisis Is Associated With Differences in Cortisol Excretion in Patients With Secondary Adrenal Insufficiency.</pubmed_title><pmcid>PMC9065259</pmcid><pubmed_authors>van Faassen M</pubmed_authors><pubmed_authors>Kerstens MN</pubmed_authors><pubmed_authors>van Beek AP</pubmed_authors><pubmed_authors>Vulto A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Susceptibility to Adrenal Crisis Is Associated With Differences in Cortisol Excretion in Patients With Secondary Adrenal Insufficiency.</name><description>&lt;h4>Objective&lt;/h4>To compare cortisol pharmacokinetics and pharmacodynamics mapped through several glucocorticoid sensitive pathways in patients on hydrocortisone substitution with or without an adrenal crisis.&lt;h4>Design&lt;/h4>A &lt;i>post-hoc&lt;/i> analysis of a previously conducted randomized controlled trial in patients with secondary adrenal insufficiency examining the effects of 2 weight-adjusted hydrocortisone doses.&lt;h4>Methods&lt;/h4>Comparisons were primarily made on a hydrocortisone dose of 0.2-0.3 mg/kg/day for plasma cortisol and cortisone, 24-hour urinary steroid profile, the glucocorticoid sensitive tryptophan-kynurenine pathway, the renin-angiotensin-aldosterone system and aspects of quality of life. Variables of interest were also analyzed on the hydrocortisone dose of 0.4-0.6 mg/kg/d</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-18T12:14:45.182Z</modification><creation>2025-04-06T21:54:04.348Z</creation></dates><accession>S-EPMC9065259</accession><cross_references><pubmed>35518935</pubmed><doi>10.3389/fendo.2022.849188</doi></cross_references></HashMap>